SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050870
Filing Date
2020-11-05
Accepted
2020-11-05 07:30:42
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-10q_20200930.htm 10-Q 2300437
2 EX-31.1 dyn-ex311_6.htm EX-31.1 8278
3 EX-31.2 dyn-ex312_7.htm EX-31.2 7975
4 EX-32.1 dyn-ex321_8.htm EX-32.1 4774
5 EX-32.2 dyn-ex322_9.htm EX-32.2 4472
  Complete submission text file 0001564590-20-050870.txt   5490895

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dyn-20200930.xml EX-101.INS 792361
7 XBRL TAXONOMY EXTENSION SCHEMA dyn-20200930.xsd EX-101.SCH 38981
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyn-20200930_cal.xml EX-101.CAL 29576
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyn-20200930_def.xml EX-101.DEF 128415
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20200930_lab.xml EX-101.LAB 328354
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20200930_pre.xml EX-101.PRE 254710
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 201288686
SIC: 2834 Pharmaceutical Preparations